|$5.6 million awarded to Kaiser Permanente researcher to study treatments for type 2 diabetes|
A research team led by Romain S. Neugebauer, PhD, an investigator at the Kaiser Permanente Northern California Division of Research, and Patrick O’Connor, MD, an investigator at HealthPartners Institute, received a $5.6 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to study the benefits — and potential harms — on heart health of the second-line medications used to treat type 2 diabetes.
|Food banks tackling diabetes? Feeding America releases pilot intervention results|
Food banks can improve food security, dietary intake and health status for vulnerable individuals, such as those with diabetes Type 2, according to a new report from Feeding America.
|Depressed pregnant women more likely to eat poorer diets, Kaiser Permanente analysis finds|
Pregnant women with depression were more likely to eat poor diets with a higher intake of empty calories and lower intake of greens, beans, and fruit, according to an analysis of 1,160 adult pregnant women who were treated at Kaiser Permanente Northern California.
|Heart Risks Are Similar With Human and Analogue Insulin, at Least Initially|
People with type 2 diabetes who start taking insulin to manage their blood sugar may have a similarly low risk of developing or dying from cardiovascular problems regardless of the type of insulin they use, a new study suggests.